144 related articles for article (PubMed ID: 15196208)
1. Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.
Moody JL; Jirik FR
Immunology; 2004 Jul; 112(3):404-12. PubMed ID: 15196208
[TBL] [Abstract][Full Text] [Related]
2. Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice.
Moody JL; Pereira CG; Magil A; Fritzler MJ; Jirik FR
Genes Immun; 2003 Jan; 4(1):60-6. PubMed ID: 12595903
[TBL] [Abstract][Full Text] [Related]
3. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
4. Role of SHIP-1 in the adaptive immune responses to aeroallergen in the airway.
Roongapinun S; Oh SY; Wu F; Panthong A; Zheng T; Zhu Z
PLoS One; 2010 Nov; 5(11):e14174. PubMed ID: 21151496
[TBL] [Abstract][Full Text] [Related]
5. Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia.
Moody JL; Xu L; Helgason CD; Jirik FR
Blood; 2004 Jun; 103(12):4503-10. PubMed ID: 15001465
[TBL] [Abstract][Full Text] [Related]
6. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.
Luo J; Sobkiw CL; Logsdon NM; Watt JM; Signoretti S; O'Connell F; Shin E; Shim Y; Pao L; Neel BG; Depinho RA; Loda M; Cantley LC
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10238-43. PubMed ID: 16006513
[TBL] [Abstract][Full Text] [Related]
7. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
8. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses.
Tarasenko T; Kole HK; Chi AW; Mentink-Kane MM; Wynn TA; Bolland S
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11382-7. PubMed ID: 17585010
[TBL] [Abstract][Full Text] [Related]
9. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo.
Borlado LR; Redondo C; Alvarez B; Jimenez C; Criado LM; Flores J; Marcos MA; Martinez-A C; Balomenos D; Carrera AC
FASEB J; 2000 May; 14(7):895-903. PubMed ID: 10783143
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice.
Yoshino S; Yamaki K; Li X; Sai T; Yanagisawa R; Takano H; Taneda S; Hayashi H; Mori Y
Immunology; 2004 Jul; 112(3):489-95. PubMed ID: 15196218
[TBL] [Abstract][Full Text] [Related]
11. SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.
Kuroda E; Antignano F; Ho VW; Hughes MR; Ruschmann J; Lam V; Kawakami T; Kerr WG; McNagny KM; Sly LM; Krystal G
J Immunol; 2011 Jan; 186(1):323-32. PubMed ID: 21131429
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility.
Harris SJ; Parry RV; Foster JG; Blunt MD; Wang A; Marelli-Berg F; Westwick J; Ward SG
J Immunol; 2011 Apr; 186(8):4936-45. PubMed ID: 21402888
[TBL] [Abstract][Full Text] [Related]
13. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
Ngoh EN; Weisser SB; Lo Y; Kozicky LK; Jen R; Brugger HK; Menzies SC; McLarren KW; Nackiewicz D; van Rooijen N; Jacobson K; Ehses JA; Turvey SE; Sly LM
Gastroenterology; 2016 Feb; 150(2):465-76. PubMed ID: 26481854
[TBL] [Abstract][Full Text] [Related]
14. Impaired Fas response and autoimmunity in Pten+/- mice.
Di Cristofano A; Kotsi P; Peng YF; Cordon-Cardo C; Elkon KB; Pandolfi PP
Science; 1999 Sep; 285(5436):2122-5. PubMed ID: 10497129
[TBL] [Abstract][Full Text] [Related]
15. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
[TBL] [Abstract][Full Text] [Related]
16. T cell-specific loss of Pten leads to defects in central and peripheral tolerance.
Suzuki A; Yamaguchi MT; Ohteki T; Sasaki T; Kaisho T; Kimura Y; Yoshida R; Wakeham A; Higuchi T; Fukumoto M; Tsubata T; Ohashi PS; Koyasu S; Penninger JM; Nakano T; Mak TW
Immunity; 2001 May; 14(5):523-34. PubMed ID: 11371355
[TBL] [Abstract][Full Text] [Related]
17. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
Wain CM; Westwick J; Ward SG
Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
[TBL] [Abstract][Full Text] [Related]
18. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development.
Kashiwada M; Cattoretti G; McKeag L; Rouse T; Showalter BM; Al-Alem U; Niki M; Pandolfi PP; Field EH; Rothman PB
J Immunol; 2006 Apr; 176(7):3958-65. PubMed ID: 16547230
[TBL] [Abstract][Full Text] [Related]
19. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
